Nuvalent Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nuvalent inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nuvalent Inc Today - Breaking & Trending Today

4,500 Shares in Nuvalent, Inc. (NASDAQ:NUVL) Purchased by Harvest Investment Services LLC

Harvest Investment Services LLC bought a new stake in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 4,500 shares of the company’s stock, valued at approximately $331,000. A number of other hedge funds also recently added to or […] ....

Matthew Shair , Leerink Partnrs , Fred Alger Management , Jefferies Financial Group , Harvest Investment Services , Nuvalent Inc , Jpmorgan Chase Co , First Turn Management , Securities Exchange Commission , Victory Capital Management Inc , Charles Schwab Investment Management Inc , Invesco Ltd , Free Report , Turn Management , Capital Management , Schwab Investment Management , Alger Management , Get Free Report , Darlene Noci , Exchange Commission , Director Matthew Shair , Financial Group , Visit Holdingschannel , Nuvalent Daily ,

ARROS-1 Trial of Zidesamtinib Aims to Address Current TKI Limitations in ROS1+ NSCLC

ARROS-1 Trial of Zidesamtinib Aims to Address Current TKI Limitations in ROS1+ NSCLC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United States , Georgetown University , District Of Columbia , Stephenv Liu , Crizotinib Xalkori , European Organisation For Research , Nuvalent Inc , National Cancer Institute , American Association For Cancer Research Symposium , Georgetown Lombardi Comprehensive Cancer Center , Demonstrates Early Phase Efficacy , European Organisation , American Association , Cancer Research , North America , Heart Therapeutics ,

Nuvalent (NASDAQ:NUVL) Rating Reiterated by Wedbush

Wedbush reiterated their outperform rating on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a research note released on Friday morning, Benzinga reports. Wedbush currently has a $99.00 price objective on the stock. Other analysts have also issued reports about the stock. Jefferies Financial Group started coverage on shares of Nuvalent in a research note […] ....

Matthew Shair , Robertw Baird , Securities Exchange Commission , Darwin Global Management Ltd , Jefferies Financial Group , Nuvalent Inc , Vanguard Group Inc , Dimensional Fund Advisors , Perceptive Advisors , Free Report , Financial Group , Moderate Buy , Get Free Report , Darlene Noci , Exchange Commission , Director Matthew Shair , Global Management , Fund Advisors , Nuvalent Daily ,

Nuvalent, Inc. (NASDAQ:NUVL) Director Sells $2,469,000.00 in Stock

Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) Director Matthew Shair sold 37,500 shares of Nuvalent stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $65.84, for a total transaction of $2,469,000.00. Following the completion of the sale, the director now directly owns 1,424,698 shares of […] ....

Leerink Partnrs , Matthew Shair , Jpmorgan Chase Co , Nuvalent Company Profile , Jefferies Financial Group , Mount Yale Investment Advisors , Darwin Global Management Ltd , Nuvalent Inc , Vanguard Group Inc , Proshare Advisors , Get Free Report , Director Matthew Shair , Financial Group , Global Management , Yale Investment Advisors , Eight Capital , Share Advisors , Nuvalent Daily ,

Nuvalent Receives U.S. FDA Breakthrough Therapy Designation For NVL-655

Nuvalent Receives U.S. FDA Breakthrough Therapy Designation For NVL-655
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Prnewswire Nuvalent Inc , Drug Administration , Exchange Commission , Nuvalent Inc , Darlene Noci , Chief Development Officer , Private Securities Litigation Reform Act , Quarterly Report ,